Withdrawn trial sought to shield brain from radiation damage
NCT ID NCT05720624
Summary
This early-stage study aimed to test if a drug called AEO could help protect or restore normal brain function after standard radiation treatment for brain cancer. The trial planned to enroll adults with brain tumors who were scheduled for or had recently completed radiation. It was designed to check if collecting spinal fluid was a practical way to measure the drug's effects, but the study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT CENTRAL NERVOUS SYSTEM NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.